Resveratrol is a phenolic derivative found in certain plants, peanuts and in the skin of black grapes. It is found in significant quantities in red wine. The results obtained by this research demonstrate how resveratrol improves energy expenditure in mice and protects them against obesity and diabetes.
The study was headed by Johan Auwerx, Professor at the Institute of Genetics and Molecular and Cellular Biology (3). At the macroscopic level, researchers have noticed that a dietary supplement of resveratrol had a considerable effect on the muscles of mice. In the presence of resveratrol, muscle fibres display a high oxygen consumption and therefore high energy expenditure during exercise, where they exhibit a surprising level of endurance, as well as during periods of inactivity.
At the molecular level, the researchers have studied the signalling pathway taking part in this process, leading them to the mitochondrion (4). This organelle, found in large numbers within muscle cells is responsible for energy production. They observed that resveratrol activates a protein from the Sirtuin (5) family (SIRT1) which then leads to an increased activity of another protein involved in mitochondrial function. By acting on the mitochondria, resveratrol enhances energy expenditure and therefore the reduction in weight gain.
Furthermore, this study links sirtuins with energy expenditure and raises the possibility of using SIRT1 activators as a means of prevention or treatment of metabolic disorders. For this reason, the sirtuins reveal themselves as attractive pharmacological targets. From a therapeutic point of view they would be potentially beneficial in certain pathologies related to mitochondrial dysfunction, which is often the case for disorders associated with aging such as obesity and Type 2 diabetes.
In order to substantiate these results in humans, the company Sirtris pharmaceuticals have just started a clinical trial on diabetes using SRT501, a confidential formulation of resveratrol which has better bioavailability (6).
1 Group of Pere Puigserver, at the Dana Farber Cancer Institute/Harvard Medical School, Boston.
2 Group of Markku Laakso at the University of Kuopio in Finland.
3 Institut de génétique et de biologie moléculaire et cellulaire (IGBMC): UMR 7104 / UMR_S 596. Joint ULP / CNRS / Inserm research unit.
4 Mitochondrion: Intracellular organelle where the energy provided by organic molecules is generated and stored. The mitochondrion is the energy powerhouse of the cell
5 Sirtuins : Recently discovered family of enzymes contributing to the healthy functioning of the cell.
6 Bioavailability: capacity of a substance to be absorbed by body tissue
Isabel Pellon Zarragoitia | alfa
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Earth Sciences
05.12.2016 | Physics and Astronomy
05.12.2016 | Life Sciences